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Purpose: To develop a highly accurate molecular assay for evaluating the efficacy of metronidazole 
and some antifungal agents with meglumine antimoniate against L. infantum visceral leishmaniasis in 
different mouse tissues. 
Methods:  The assay was performed with the Light-Cycler system using SYBR Green I and primers 
amplifying ca. 120-bp fragment from minicircles of the kinetoplast DNA (kDNA).The mice were divided 
into two groups. Group I served to evaluate drug activity and parasite load while Group II was assigned 
to identify possible synergistic activity between meglumine (which is highly effective in the liver but less 
effective in the spleen) and drugs with significant activity against spleen infection.  
Results: The assay was able to detect as little as 100 fragments of L. major DNA per reaction, which is 
equivalent to 0.1 parasites. The standard curve designed for quantitation of parasites showed linearity 
over at least 6-log DNA concentration range, corresponding to 0.1 to 10
4
 parasites per reaction with a 
correlation coefficient of 0.979. Metronidazole, ketoconazole, fluconazole, itraconazole and terbinafine 
were less effective than antimonial agents in reducing hepatic parasite load while ketoconazole 
potentiated the effect of meglumine antimoniate reference therapy through its marked activity against 
spleen infection (L. infantum visceral leishmaniasis). 
Conclusion: The assay technique is accurate, sensitive, and rapid for the detection of kDNA and would 
be of great help to scientists who use animals to monitor the efficacy of anti-leishmanial drugs or 
vaccines.  
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INTRODUCTION 
 
Leishmaniases are a group of parasitic 
diseases of major and growing public health 
importance [1]. Leishmania species are 
intracellular protozoa that affect humans and 
dogs worldwide and are transmitted by the 
bite of hematophagous sand flies. About 21 
Leishmania species have been reported to 
cause human infection [2]. They cause a 
large spectrum of diseases, ranging from 
spontaneously healing skin lesions to fatal 
visceral symptoms, if left untreated. Two 
million new human cases arise every year, 
and at least 350 million peoples are exposed 
to the risk of Leishmania parasite infection 
[3]. Experimental hosts, such as laboratory 
mice, are largely used to study the 
immunobiology of these parasites and to 
screen the efficacy of newly developed drugs 
and vaccines [4]. Most of those studies 
require detection and quantitation of the 
Leishmania burdens in different mouse 
tissues. This is still routinely performed by 
culture-based techniques [5]. These positive 
diagnostic methods for Leishmaniasis such 
as direct smear examination and culture, 
have major limitations. Direct examination 
requires some expertise and lacks sensitivity, 
culture is labor-intensive, and the result is not 
known for weeks [6]. 
 
By contrast, PCR assay provides results in 
one or two working days. PCR-based 
methods for detecting Leishmania species 
have been developed to amplify rRNA genes, 
miniexon genes, kinetoplast DNA (kDNA), 
and repetitive nuclear sequences [7]. 
Recently, a PCR-based assay to quantify the 
parasite load in mice infected with L. major 
using primers from the conserved sequences 
of kDNA [8] was reported. However, this 
technique is still cumbersome as it requires 
agarose gel image analysis. A more rapid 
alternative is real-time quantitative PCR, 
which quantifies DNA and has the potential 
for accurate microorganism enumeration in 
medical [9], environmental [10] and food 
samples [11].  
 
Visceral leishmaniasis (VL) caused by 
Leishmania infantum, remains difficult to treat 
in patients with AIDS due to parasite 
resistance and high rates of relapse. There is 
a need for an alternative to antimonial agents 
and amphotercin B, especially for drugs that 
are effective by the oral route. Metronidazole 
and sterol biosynthesis inhibitors (ketoco-
nazole, fluconazole, itraconazole and 
terbinafine) are well-tolerated drugs that are 
potentially active against Leishmania when 
given by mouth. It has been shown that 
Leishmania donovani experimentally resistant 
to amphotercin B is highly susceptible to 
ketoconazole. [12]. In this study, we tested  
the application of real-time LC-PCR by 
evaluating  the efficacies of metronidazole 
and some antifungal agents with meglumine 
antimoniate against L. infantum visceral 






Five- to 6-week-old mice, weighing 20 - 30 g. 
were purchased from Theodor Bilharz 
Research Institute TBRI, Egypt. Approval of 
the institutional animal ethical committee for 
the animal studies was obtained from the 
Office of Environmental Health and Radiation 
Safety, ACUC Protocol # 1096-5. The 
animals were maintained according to 
accepted standards of human care [13]. 
 
Materials   
 
The following primers were used (forward, 5'-
CCTATTTTACACCAACCCCCAGT-3' JW11; 
reverse, 5'-GGGTAGGGGCGTTCTGCGAAA 
-3' JW12) that amplify a ca. 120-bp fragment 
of the minicircles kDNA of L. major, ca. 
10,000 copies of which are present in each 
parasite. These primers match the conserved 
sequences of the kinetoplast minicircle but do 
not match mouse frequent nucleic acid 
sequences according to the PCR-Rare 
software. The primers were obtained from 
Genset (Paris, France) as EasyOligos. 
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 Leishmania strains and DNA extraction 
 
L. major strain NIH173 (MHOM/IR/-/173), L. 
donovani LV9 (MHOM/ET/1967/Hu3:LV9), L. 
infantum 2176 (MHOM/FR/1991/LEM/2176), 
L. amazonensis LV79 (MNYC/BZ/1962/ 
M1841), and L. mexicana M379 (MNYC/ 
BZ/1962/M379) were cultured according to 
the method of  [14]. Briefly, at 26 
0
C in 
Hosmem-ll medium supplemented with 10% 
heat-inactivated Fetal Calf Serum (FCS), 100 
pg of penicillin/ml and 100 pg of 
streptomycin/ml, stationary-phase promasti-
gotes of the different strains were harvested 
by centrifugation, washed twice with PBS, 
enumerated with a hemocytometer, pelleted 
and stored at -80 
0
C until DNA extraction. 
Genomic DNA was extracted from 
approximately 2 x 10
7 
promastigotes with a 
DNeasy Tissue kit (Strata Gene Inc, USA) in 
accordance with the manufacturer's protocol.  
 
Source of mouse tissue DNA  
 
Mice were infected intradermally at the ear 
with 10
4
 metacyclic promastigotes of L. major 
strain NIH 173 and killed at 6 or 12 months 
post-infection. Other mice were infected in 
the footpad with 2 x 10
6
 amastigotes of L. 
amazonensis strain LV79 or L. mexicana 
strain M379 and killed at 12 or 32 weeks 
post-infection, respectively.  Bone marrow 
and spleens were also collected from mice 
infected with L. donovani strain LV9 as 
previously described [15].  
 
Real-time PCR with LC  
 
A real-time hot-start PCR was performed with 
LC FastStart DNA Master SYBR Green I Kit 
(Roche Diagnostics, Meylan, France) in an 
LC (Roche Diagnostics). The 12-µl reaction 
mixture contained I x LC FastStart DNA 
Master SYBR Green I, 2 mM MgCl2, 0.5 µM 
each primer and 1.2 µl of template. Times 
and temperatures are shown in Table 1. For 
fluorescence signal acquisition, channel F1 
was used and the gain was set at 5. For 
normalization of fluorescent data, the Fl/1 
ratio was applied. 
 
Table 1: Times and temperatures used for PCR 
configuration with SYBR Green I and LightCycler  
 







Denaturation 95 8 20 None 
95 10 20 None 
56 10 20 None 
Amplification  
(40 cycles) 
72 8 20 Single 
95 10 20 None 
67 30 20 None Melting 
95 10 0.1 Continue 
Cooling 40 60 20 None 
 
Application of anti-Leishmania chemothe-
rapy 
 
Group I  
 
Drug screening to evaluate drug activity, 
parasite loads in the liver and spleen of mice 
treated from days 7 to 17 were determined on 
day 20 using real time LC-PCR. Parasite load 
was expressed as the log10 number of 
parasites per gram of tissue, and the mean (± 
SD) parasite load for four mice was 
calculated. Drug administration was daily, by 
mouth, for treatment with metronidazole (70 
and 140 mg/kg), ketoconazole (50 and 100 
mg/kg), fluconazole (50 and 100 mg/kg), 
itraconazole (50 and 100 mg/kg) and 
terbinafine (100 mg/kg) and daily by 
intraperitoneal injection, for treatment with 




This was designed to identify possible 
synergistic activity between meglumine 
antimoniate which is highly effective in the 
liver but less effective in the spleen and for 
drugs with significant activity against spleen 
infection. The efficacies of ketoconazole and 
metronidazole alone and in combination with 
meglumine antimoniate were examined and 
compared with those in untreated mice and in 
mice-treated with meglumine antimoniate 
alone. Each group comprised 12 mice.   
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Statistical analysis 
 
Assay results are shown as mean ± SD and 
reported as the coefficient of variation. 
Statistical and regression analyses were 
carried out with Sigma Plot software (SPSS 
Inc., Chicago, USA). Differences were 





LC PCR development 
 
The JW 11 and JW12 primers, which amplify 
a ca 120-bp DNA fragment from L. major 
kinetoplast minicircles, were used. A 100-pg 
sample of DNA extracted from in vitro grown 
promastigotes of L. major NIH 173 was used 
as the template for the establishment of the 
LC-PCR assay, in particular, for the 
determination of the optimal annealing 
temperature and magnesium chloride 
concentration. Agarose gel electrophoresis of 
the PCR product confirmed the amplification 
of a ca 120-bp DNA fragment.  
 
Detection of kDNA from other Leishmania 
species 
 
Primers JW11 and JW12 were able to amplify 
a ca 120-bp DNA fragment from 
promastigotes of L. donovani LV9, L. 
infantum 2176, L. amazonensis LV 79 and L. 
mexicana M379 by conventional PCR. 
Therefore, the same primers were also 
assessed for amplification of kDNA in our 
assay. The sensitivity of the LC-PCR assay 
for detection of these strains was similar to 
that of L. major NIH 173, except for L. 
mexicana strain M379, for which the assay 
was approximately 100 times less sensitive 
(Table  2). The intra-assay variation 
coefficient was < 1.2 % showing good 
reproducibility of the assay for those 
Leishmania species as well. 
 
Comparison of real-time PCR and 
conventional PCR for Leishmania 
detection 
 
DNA was extracted from various tissues of 
BALB/c infected mice with various 
Leishmania strains (Table 3) and assayed 
with either a conventional PCR or the LC 
PCR. In the latter, the standard curve of the 
respective species was used to generate a 
relative Leishmania burden based on CT 
values. In all of the assays, the CT values of 
negative controls were always >36. Whatever 
the tissue and the strain, all of the samples 
that were positive by the conventional PCR 
were also positive by the LC assay and most 
of the CT values were far below the negative 
CT value threshold of 36. In addition, a few 
samples that were negative by conventional 
PCR were positive by real-time PCR. 
 
Table 2: Mean CT values and intraassay SDs of dilution series of promastigote DNAs from different 
leishmania species 
 
Leishmania species Mean CT value ± SD  
No. of parasites/reaction 1,000 100 10 1 0.1 
L. major NIH 173 21.06±0.260 25.51±0.057 29.46±0.160 33.05±0.446 35.85±0.153 
L. donovani LV9 17.71±0.017 21.75±0.070 24.57±0.055 28.83±0.228 32.29±0.224 
L. infantum 2176 19.95±0.011 24.36±0.272 28.90±0.006 33.39±0.051 
a
ND 
L. amazonensis LV79 19.37±0.121 23.42±0.266 27.48±0.250 32.14±0.075 34.18±0.122 
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Table 3: Real-time and conventional PCR assay data for leishmania kDNA in mouse tissue  
 
 







 1-6 L. major Ear - >36           - 
 7 L. major Ear + 28.61           + 
 8 L. major Ear + 22.66           + 
 9 L. major Ear + 24.64           + 
 10 L major Ear + 34.94           + 
 11 L. major Ear - 35.14           + 
 12 L. major Ear - >36           - 
 13 L. major Lymph node + 29.68           + 
 14 L. major Lymph node + 30.68           + 
 15 L. major Lymph node + 23.77           + 
 16-18 L. major Tail skin - >36           - 
 19 L. mexicana Blood - >36           - 
 20 L. mexicana Blood + 31.42           + 
 21 L. mexicana Blood - 33.05           + 
 22 L. mexicana Bone marrow + 28.80           + 
 23 L mexicana Bone marrow + 21.44           + 
 24 L. mexicana Lesion + 17.94           + 
 25 L mexicana Lesion + 18.16           + 
 26 L. mexicana Lesion + 16.46           + 
 27 L. mexicana Liver + 23.66           + 
 28 L. mexicana Liver + 24.46           + 
29    L mexicana Lymph node + 19.81           + 
30   L. mexicana Lymph node + 20.70           + 
31   L mexicana Spleen + 24.61           + 
32   L. mexicana Spleen + 20.96           + 
33   L. mexicana Tail skin + 23.89           + 
34   L mexicana Tail skin + 15.36           + 
35   L. mexicana Tail skin + 18.67           + 
36  L. amazonensis Blood - >36           - 
37  L. amazonensis Lesion + 15.81           + 
38  L. amazonensis Liver - >36           - 
39  L. amazonensis Lymph node + 25.42           +    
40  L. amazonensis Spleen - >36           - 
41  L. amazonensis Tail skin - 29.97           + 
42   L. donovani Bone marrow + 22.73           + 
43   L. donovani Bone marrow + 27.87           + 
44   L. donovani Bone marrow + 28.44           + 
45   L. donovani Spleen + 19.64           + 
46   L. donovani Spleen + 19.88           + 
47   L. donovani Spleen + 23.56           + 
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Values are expressed as mean ± SD for six mice; * significantly different from value for untreated mice at p < 0.001 
 
Evaluation of 1st and 2nd line anti-
leishmania chemotherapy 
 
Group  I treatment 
 
None of the test compounds administered 
alone from days 7 to 17 significantly reduced 
parasite load in the liver by day 20, compared 
to that in infected untreated control mice (see 
Table 4). By contrast, the parasite load in the 
spleen of treated mice fell by 1 to 4 log10 
parasite/g relative to the parasite load in the 
controls. Ketoconazole was the most 
effective of the drugs tested, since the 
parasite loads were markedly reduced at a 
dose of 50 mg/kg/day and were undetectable 
in mice treated with 100 mg/kg/day (p < 
0.01), compared to results for untreated mice. 
Treatment with metronidazole or fluconazole 
at a dose of 50 mg/kg/day, also significantly 
reduced parasite load in spleen, when 
compared to that in infected untreated control 
mice. Surprisingly, treatment with fluconazole 
at 50 mg/kg/day seemed slightly more 
effective in spleen infection than that at 100 
mg/kg/day. However, this effect is limited and 
individual variations between mice may 
partially explain such a difference. 
 
Group II animals treatment 
 
Meglumine antimoniate was highly effective 
in the liver, and treatment with ketoconazole 
resulted in the lowest spleen load. 
Interestingly, no parasites were detected on 
day 20 in the liver or spleen of mice treated 
with meglumine antimoniate plus 
ketoconazole or metronidazole. However, 
relapse was observed with both combinations 
at day 60, with parasite counts in the spleen 
comparable to those in mice treated with 




A new molecular real-time PCR assay for 
detection and quantification of L. major and 
several other Leishmania species of medical 
importance is described. This assay is based 
on the LC system with SYBR Green I. This 
quantitative LC PCR assay allows highly 
sensitive and reproducible detection and 
quantitation of parasite burden over a wide 
range, at least 6 logs, of parasite 
concentrations. The very high sensitivity (less 
than 0.1 parasites per reaction) is partly due 
to the high copy number of the target 
minicircle kDNA, which is present at ca. 
10,000 copies per parasite. This avoids the 
use of internal molecular probes and 
therefore limits the cost of the assay. 
Including the DNA extraction step, the assay 
can be performed within 4 to 5 h without risk 
of contamination, as the reaction capillary 
remained closed.  
Group 1 treatment Dose 
(mg/kg/day) 
Day Log10 parasites/g of tisuue
a
                
Liver                      Spleen 
Control  7 
20 
4.66±0.18              1.83±2.14 





4.66±0.21              0.86±1.76 





4.94±0.28              0.85±1.70* 





4.72±0.30               2.51±2.19        
4.48±0.60              1.14±1.89 





4.55±0.23             1.13±2.26* 
4.67±0.53            1.03±2.06* 
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Table 5: Parasite load on days 20 and 60 in the liver and spleen of L. infantum-infected mice treated from 
days 7 to 17 
 
Group II treatment Day Log10 parasites/g of tissue
a
 
Liver                       Spleen 
None (control) 7 
20 
60 
3.87±0.07               1.45±1.74 
4.77±0.35               3.56±0.29 
4.57±0.27               4.79±0.51 
Ketoconazole(50mg/kg/day) 20 
60 
4.69±0.26               0.68±1.66 
3.94±0.35               4.72±0.14 
Metronidazole(70mg/kg/day) 20 
60 
4.89±0.32               2.13±1.56 






0*                            0* 






0*                           0* 
0*                           3.17±1.62 
 
a
Values are expressed as mean ± SEM for six mice*, significantly different from value for untreated mice at p < 0.001
 
Application of real-time PCR for research and 
clinical diagnosis in parasitology is a useful 
technique and so far concerns mainly 
Toxoplasma gondii [16] and L. infantum 
[17]. With primers common to several 
Leishmania species, our assay technique 
can also be used to determine relative 
parasite burden in mouse tissues infected 
with L. amazonensis and L. donovani and 
to a lesser extent, in mouse tissues infected 
with L. mexicana based on CT values. In a 
previous study, preliminary assays have 
shown the PCR yield may be influenced by 
tissue DNA concentration above a threshold. 
Therefore, we are evaluating new developing 
internal standards based on housekeeping 
genes to determine parasite burden more 
accurately. Identification of a Leishmania 
infection for laboratory clinical diagnosis by 
culture or serological techniques requires a 
long time and has poor specificity.  
With the development of a real-time PCR 
assay that can be improved for identification 
of Leishmania species with internal probes or 
different primers, as done previously with 
other pathogenic microorganisms such as 
Campylobacter spp [18], Neisseria 
meningitides, Haemophilus influenza and 
Streptococcus  
 
pneumonia [19], we hope the assay will 
enhance the current serology technique. In 
addition, a large field of application for the 
assay is monitoring of Leishmania infection, 
life cycle development, diagnosis, treatment 
with follow up and vaccine development in 
research experiments. Our studies indicate 
that LC-PCR improves the reliability of 
positive diagnosis and yields quantitative 
results for assessment of treatment efficacy. 
In an experimental mouse model previously 
used to test the efficacy of amphotercin B, 
lipid formulations of amphotercin B and 
aminosidine [20], the efficacies of 
metronidazole and antifugal agents against L. 
infantum (VL) were compared. 
Metronidazole, ketoconazole, fluconazole, 
itraconazole and terbinafine were less 
effective than antimonial agents in reducing 
hepatic parasite load. Ketoconazole 
potentiated the effect of antimoniate 
reference therapy through its marked activity 
against spleen infection. 
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CONCLUSION 
 
The pentavalent derivatives of antimony are 
highly effective, since parasite burden were 
at an undetectable level in the liver. However, 
parasite foci persisted in the spleen, and this 
probably explains the occurrence of relapse. 
Despite being less effective than meglumine 
antimoniate in monotherapy, ketoconazole 
and metronidazole were the most effective 
second line treatments in this study. 
Furthermore, their combination with 
meglumine antimoniate resulted in marked 
decreases in parasite loads in both liver and 
spleen. However, the relapses that were 
observed in susceptible BALB/c mice treated 
with these combinations indicate the 
inefficacy of the host immune functions in 
clearing parasites when anti-leishmanial drug 
concentration decreased and/or the drug did 
not reach the parasitophorous vacuole. With 
regard to the use of marked drug carrier 
systems with meglumine antimoniate, 
ketoconazole, or metronidazole in order to 
reach sustained drug levels and to target the 
drugs toward infected tissues, the results 
obtained emphasize the need for multidrug 
therapy as well as maintenance therapy in 
the treatment of L. infantum visceral 
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